You are here
Not Available
Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: N43CO201000096
Agency Tracking Number: N43CO201000096
Amount:
$297,532.00
Phase:
Phase I
Program:
SBIR
Solicitation Topic Code:
NCI
Solicitation Number:
PHS2010-1
Timeline
Solicitation Year:
2010
Award Year:
2010
Award Start Date (Proposal Award Date):
N/A
Award End Date (Contract End Date):
N/A
Small Business Information
100 RIVER PLACE, SUITE 6800
DETROIT, MI
48207-
United States
DUNS:
044306905
HUBZone Owned:
No
Woman Owned:
Yes
Socially and Economically Disadvantaged:
No
Principal Investigator
Name: Nalini Motwani
Phone: (313) 446-2625
Email: nmotwani@apolife.com
Phone: (313) 446-2625
Email: nmotwani@apolife.com
Business Contact
Phone: (313) 446-2625
Email: nmotwani@apolife.com
Email: nmotwani@apolife.com
Research Institution
N/A
Abstract
ApoLife is developing yeast platform-Twin Cassette yeast vectors for cost effective manufacturing of antibodies. Using recent collaboration with a company with proprietary S. cerevisiae yeast strains producing homogeneous human N-linked glycosylated proteins, ApoLife will develop commercial scale process for cost effective manufacturing of Campth, anticancer antibody, as a biogeneric antibody candidate. ApoLife has expressed Campath genes in yeast system.
* Information listed above is at the time of submission. *